DAX21.254 +1,0%ESt505.206 +0,8%Top 10 Crypto16,84 +3,2%Dow44.157 +0,3%Nas20.009 +1,3%Bitcoin98.251 -1,3%Euro1,0409 ±-0,0%Öl78,74 -0,3%Gold2.751 -0,2%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
NVIDIA 918422 Siemens Energy ENER6Y Rheinmetall 703000 Tesla A1CX3T Apple 865985 Oracle 871460 Bayer BAY001 Amazon 906866 Netflix 552484 Deutsche Bank 514000 BASF BASF11 Mercedes-Benz Group (ex Daimler) 710000 Deutsche Telekom 555750 Microsoft 870747 Volkswagen (VW) vz. 766403
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Rekordlaune hält an: DAX schließt deutlich fester -- Wall Street letztlich im Plus -- Netflix verzeichnet Rekord-Plus -- adidas übertrifft Jahresprognose -- Reddit, VW, Tempus AI im Fokus
Top News
So bewertet Goldman Sachs Cybersecurity-Aktien für 2025 So bewertet Goldman Sachs Cybersecurity-Aktien für 2025
Ausblick 2025: Chancen und Herausforderungen für Anleihen-ETFs Ausblick 2025: Chancen und Herausforderungen für Anleihen-ETFs
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Amgen Aktie

NeuKaufenVerkaufen
Amgen Aktien-Sparplan
264,00 EUR +1,05 EUR +0,40 %
FSE
274,33 USD +0,74 USD +0,27 %
nachbörslich
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.141,89 Mrd. EUR

KGV23,07Div. Rendite2,96%

WKN867900

ISINUS0311621009

SymbolAMGN

Amgen Aktien News

DatumMeistgelesen
ZacksAmgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
PR NewswireLA LA ANTHONY PARTNERS WITH AMGEN TO SHARE CANDID, BEHIND-THE-SCENES LOOK AT HOW PLAQUE PSORIASIS AFFECTS HER LIFE
ZacksAmgen (AMGN) Ascends While Market Falls: Some Facts to Note
PR NewswireTEPEZZA® (TEPROTUMUMAB) RECEIVES APPROVAL IN JAPAN FOR THE TREATMENT OF ACTIVE THYROID EYE DISEASE
ZacksAmgen (AMGN) Stock Declines While Market Improves: Some Information for Investors
PR NewswireAMGEN TO HOST CONFERENCE CALL TO DISCUSS NEW TOPLINE DATA IN INFLAMMATION AND RARE DISEASE
BenzingaWhat the Options Market Tells Us About Amgen
MotleyFoolAmgen vs. Viking Therapeutics: What's the Better GLP-1 Stock to Buy?
MotleyFoolWhere Will Amgen Be in 5 Years?
ZacksAmgen (AMGN) Stock Dips While Market Gains: Key Facts
ZacksInvestors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know
ZacksAmgen (AMGN) Rises Higher Than Market: Key Facts
PR NewswireAMGEN TO PRESENT DATA FROM MULTIPLE EARLY-STAGE CLINICAL TRIALS AT ESMO 2024
ZacksWhy Amgen (AMGN) Outpaced the Stock Market Today
PR NewswireAMGEN PRESENTS NEW DATA FOR FIRST-IN-CLASS IMDELLTRA™ (TARLATAMAB-DLLE) IN SMALL CELL LUNG CANCER AT WCLC 2024
ZacksHere is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
ZacksAmgen (AMGN) Up 5.8% Since Last Earnings Report: Can It Continue?
ZacksAmgen Stock Rises Almost 20% in 6 Months: Buy, Sell or Hold?
ZacksWhy the Market Dipped But Amgen (AMGN) Gained Today
PR NewswireAMGEN TO PRESENT AT THE 2024 WELLS FARGO HEALTHCARE CONFERENCE
PR NewswireAMGEN TO PRESENT AT THE MORGAN STANLEY 22ND ANNUAL GLOBAL HEALTHCARE CONFERENCE
BenzingaAmgen Unusual Options Activity For August 29
ZacksAmgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
ZacksAmgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
BenzingaAmgen Options Trading: A Deep Dive into Market Sentiment
MotleyFoolWhy Amgen Stock Is Down Today Despite Solid Q2 Results
BenzingaAmgen Faces Near-Term Challenges But Long-Term Growth Prospects Remain Strong: Analyst
ZacksAmgen (AMGN) Stock Down Despite Q2 Earnings & Sales Beat
ZacksAmgen (AMGN) Reports Q2 Earnings: What Key Metrics Have to Say
ZacksAmgen (AMGN) Q2 Earnings and Revenues Beat Estimates
BenzingaAmgen Gears Up For Q2 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
PR NewswireAMGEN ANNOUNCES 2024 THIRD QUARTER DIVIDEND
ZacksAmgen (AMGN) Advances While Market Declines: Some Information for Investors
PR NewswireAMGEN ANNOUNCES WEBCAST OF 2024 SECOND QUARTER FINANCIAL RESULTS
ZacksExploring Analyst Estimates for Amgen (AMGN) Q2 Earnings, Beyond Revenue and EPS
ZacksCan Amgen (AMGN) Keep the Beat Streak Alive in Q2 Earnings?
ZacksAmgen (AMGN) Expected to Beat Earnings Estimates: Should You Buy?
ZacksAmgen (AMGN) Advances But Underperforms Market: Key Facts
BenzingaUnpacking the Latest Options Trading Trends in Amgen
ZacksAmgen (AMGN) Stock Moves -0.39%: What You Should Know
Wer­bung

Amgen News

Amgen News: auf dieser Seite finden Sie alle Amgen News und Nachrichten zur Amgen Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Amgen News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Amgen News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.